Inhibition of cholesterol absorption by HMG-CoA reductase inhibitor
โ Scribed by T. A. Miettinen
- Publisher
- Springer
- Year
- 1991
- Tongue
- English
- Weight
- 300 KB
- Volume
- 40
- Category
- Article
- ISSN
- 0031-6970
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
The synthesis of a new 3-hydroxy-3-methylglutaryl coenzyme A reduc-----tase inhibitor starting from 4,4' -difluorobenzophenone is described. Mevinolin 1 and its congeners are potent inhibitors of 3-hydroxy-3-methyl-
The rationale for a new class of HMG CoA reductase inhibitors, represented by a,adifluoroketones 3 and 4, is described. The syntheses of 3,4, and their nonfluorinated analogue 5 are presented.
Abstmet: Upon exposure to intense simulated sunlight, CI-981 (1) readily decomposes into three major by-products. This paper reports on the products formed when I is decomposed in acetommlelwater solutions under intense simulated sunlight, ult~~~olet b&t filtered at 254 mn and visible light, In&ded
## Abstract The cholesterolโlowering drug simvastatin (SIMV, Zocor^ยฎ^) reduced heart attacks by 42% in patients who had high cholesterol levels and suffered from heart disease. Upon oral administration, SIMV is quickly hydrolyzed to its ฮฒโhydroxyacid and other acid metabolites, which are potent inh
We tested the possibility that simvastatin, a competitive inhibitor of HMG-CoA reductase related to mevinolin, might alter cholesterol saturation of gallbladder bile. Ten patients with Type IIa or IIb hypercholesterolemia underwent bile sampling before, and again after, treatment with 20 or 40 mg pe